Sign inJoin waitlistJoin the waitlist

Thomas Herzog

Professor of Clinical · University of Cincinnati Medical Center Inc.

Credentials: · · · · ·

History

University of Cincinnati Medical Center Inc.
Present

Gynecologic Oncology
Washington University School of Medicine
1993–1996
Good Samaritan Hospital (Obstetrics and Gynecology
1989–1993
University of Cincinnati College of Medicine
1982–1986
Miami University (Zoology

Research

Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer
New England Journal of Medicine · 2023 · 703 citations
Nationwide trends in the performance of inpatient hysterectomy in the United States
Obstetrics and Gynecology · 2013 · 573 citations
Bevacizumab and paclitaxel-carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study…
The Lancet Oncology · 2017 · 488 citations

Jason Wright
100 papers · 61 as a resident
Bradley Monk
83 papers
RC
Robert Coleman
74 papers
David Mutch
70 papers · 2 as a resident
Sharyn Lewin
60 papers · 5 as a resident
William Burke
53 papers · 5 as a fellow
Janet Rader
52 papers · 9 as a fellow
Matthew Powell
32 papers · 19 as a fellow
Alfred Neugut
29 papers
Dawn Hershman
29 papers
Bhavana Pothuri
24 papers
Randall Gibb
23 papers

Clinical trials

Cancer Stem Cell Assay Directed Chemotherapy in Recurrent Platinum Resistant Ovarian Cancer
Study chair · Active not recruiting · Phase 3
Cordgenics, LLC
2019–2024
Topotecan in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
Study chair · Completed · Phase 2
Gynecologic Oncology Group
2005
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Site PI · Recruiting · Phase 3
Eli Lilly and Company
2025–2031